A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.
Abroad (travel likely)RecruitingPHASE3
Conditions
Fatigue Related to Cancer Treatment · Colon Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Omega Hospital Chinna Gadhili, Visakhapatnam, Andhra Pradesh, India
Contact: Study coordinator (Dr Bella Ravi Shankar)K R Hospital, Mysore, Karnataka, India
Contact: Study coordinator (Dr. Vikas L)Jeevanjyoti Cancer Hospital, Jalgaon, Maharashtra, India
Contact: Study coordinator (Dr. Chaudhari Nitin Laxman)Sangavi Multispeciality Hospital Pvt. Ltd,, Pune, Maharashtra, India
Contact: Study coordinator (Dr. Nikhil Mallinath Shirsi)Erode Cancer Care Centre, Erode, Tamil Nadu, India
Contact: Study coordinator (Dr. K. Velavan)International Oncology Cancer Tower 1, Kanpur, Uttar Pradesh, India
Contact: Study coordinator (Dr. Sachin Anand Prakash)